Medical Technology Development and Commercialization: Hearing Before the Subcommittee on Technology of the Committee on Science, U. S. House of ... Session, November 2, 1995 (Classic Reprint) - Softcover
Synopsis
How government rules shape the future of medical technology—and what it means for faster, safer access to new devices and drugs.
This book compiles a detailed look at how tax policies, regulatory oversight, and other laws impact the development and commercialization of medical technologies. It examines why timely innovation matters for patients and for the U.S. economy, and it discusses the tradeoffs between safety, efficacy, and speed to market. The text covers perspectives from lawmakers, industry leaders, and regulators, highlighting ongoing debates about how to reform the regulatory environment without compromising public health.
- Learn how regulatory policy has evolved and what it means for new devices and therapies.
- Understand the roles of the FDA and international counterparts in device review, postmarket surveillance, and safety standards.
- See arguments for and against different reform approaches, including efficiency, cost, and patient outcomes.
- Explore scenarios where policy changes could accelerate innovation while maintaining patient safety.
"synopsis" may belong to another edition of this title.
Other Popular Editions of the Same Title
Search results for Medical Technology Development and Commercialization:...
Seller Image
Medical Technology Development and Commercialization (Classic Reprint)
Print on DemandSeller: Forgotten Books, London, United Kingdom
Seller rating 4 out of 5 stars
Paperback. Condition: New. Print on Demand. This book delves into the impact of government policies on the development and commercialization of medical technologies in the United States. The author draws on firsthand accounts from industry leaders to highlight the challenges faced by companies seeking to bring new and innovative medical devices and drugs to market. The book explores the delicate balance between ensuring public safety and fostering innovation, examining the effectiveness of existing regulations and the need for reform. It discusses the impact of policies on clinical trials, research and development, and manufacturing, raising concerns about the potential loss of U.S. leadership in medical technology and the implications for patients' access to life-saving treatments. Ultimately, the book underscores the significance of addressing these challenges to ensure continued advancements in medical technology and improve healthcare outcomes for all. This book is a reproduction of an important historical work, digitally reconstructed using state-of-the-art technology to preserve the original format. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in the book. print-on-demand item. Seller Inventory # 9781331234982_0
Buy New
US$ 19.36
Free Shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: Over 20 available
Stock Image
Medical Technology Development and Commercialization Hearing Before the Subcommittee on Technology of the Committee on Science, U S House of Session, November 2, 1995 Classic Reprint
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # LW-9781331234982
Stock Image
Medical Technology Development and Commercialization Hearing Before the Subcommittee on Technology of the Committee on Science, U S House of Session, November 2, 1995 Classic Reprint
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 4 out of 5 stars
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # LW-9781331234982
Buy New
US$ 25.92
US$ 5.57 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: 15 available